Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.56 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.56 |
| ▸ | CPT2 | P23786 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 5/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.48 |
| ▸ | PPARG | P37231 | 7/20 | 0.48 |
| ▸ | PPARD | Q03181 | 7/20 | 0.48 |
| ▸ | PPARA | Q07869 | 7/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.48 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27830424 | 0.98 | TDP1 (0.60) | TDP1FFAR1CPT2LMNATSHR | |
| SCHEMBL30503121 | 0.95 | TDP1 (0.62) | TDP1FFAR1CPT2LMNATSHR | |
| SCHEMBL28199570 | 0.95 | TDP1 (0.62) | TDP1FFAR1CPT2LMNATSHR | |
| SCHEMBL14985405 | 0.95 | TDP1 (0.62) | TDP1FFAR1CPT2LMNATSHR | |
| SCHEMBL29733581 | 0.95 | TDP1 (0.62) | TDP1FFAR1CPT2LMNATSHR | |
| SCHEMBL14359877 | 0.95 | TDP1 (0.54) | TDP1FFAR1CPT2LMNATSHR | |
| SCHEMBL14359845 | 0.93 | TDP1 (0.54) | TDP1FFAR1CPT2LMNATSHR | |
| SCHEMBL14360000 | 0.91 | TDP1 (0.58) | TDP1FFAR1CPT2LMNATSHR | |
| SCHEMBL27628078 | 0.91 | TDP1 (0.58) | TDP1FFAR1CPT2LMNATSHR | |
| SCHEMBL24443498 | 0.87 | GPR84 (0.58) | TDP1FFAR1CPT2LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9340691-B2 | Hot melt ink composition comprising a copolyester and process for preparing a copolyester | OCE-TECHNOLOGIES B.V. (NL) | 2016-05-17 | — | — | US | disclosed |
| EP-2596960-B1 | Reusable print medium and method of manufacturing thereof | OCE TECH BV (NL) | 2016-04-20 | — | — | EP | disclosed |
| US-8809432-B2 | Reusable print medium and method of manufacturing thereof | OCE TECHNOLOGIES B.V. (NL) | 2014-08-19 | — | — | US | disclosed |
| EP-2726564-A2 | HOT MELT INK COMPOSITION COMPRISING A COPOLYESTER AND PROCESS FOR PREPARING A COPOLYESTER | OCE-Technologies B.V. (NL) | 2014-05-07 | — | — | EP | disclosed |
| US-20140114013-A1 | HOT MELT INK COMPOSITION COMPRISING A COPOLYESTER AND PROCESS FOR PREPARING A COPOLYESTER | OCE-TECHNOLOGIES B.V. (NL) | 2014-04-24 | — | — | US | disclosed |
| US-8703810-B2 | Estrogen receptor modulators and uses thereof | SERAGON PHARMACEUTICALS, INC. (US) | 2014-04-22 | — | — | US | disclosed |
| US-20130137805-A1 | REUSABLE PRINT MEDIUM AND METHOD OF MANUFACTURING THEREOF | OCE TECHNOLOGIES B.V. (NL) | 2013-05-30 | — | — | US | disclosed |
| EP-2596960-A2 | Reusable print medium and method of manufacturing thereof | Océ-Technologies B.V. (NL) | 2013-05-29 | — | — | EP | disclosed |
| US-20130116232-A1 | ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | ARAGON PHARMACEUTICALS, INC. (US) | 2013-05-09 | — | — | US | disclosed |
| WO-2013000761-A2 | HOT MELT INK COMPOSITION COMPRISING A COPOLYESTER AND PROCESS FOR PREPARING A COPOLYESTER | OCE-TECHNOLOGIES B.V. (NL) | 2013-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130116232-A1 | ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | ESR2, ESRRG, GPER1 | TDP1 4369/4885FFAR1 154/4885CPT2 2219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.